Literature DB >> 3943923

Immunological consequences of tumor excision: from active immunity to immunological memory.

I Bursuker, R J North.   

Abstract

Excision of the immunogenic Meth-A fibrosarcoma during generation by the host of concomitant antitumor immunity resulted in the appearance in sequence of two qualitatively distinct states of post-excision immunity. Immunity expressed on the day of excision was dependent on Ly-1-2+, cyclophosphamide-sensitive T cells, whereas immunity expressed 2 weeks later was dependent on cyclophosphamide-resistant T cells which can be functionally eliminated by either anti-Ly-1 or anti-Ly-2 monoclonal antibody and complement. The data suggest that antitumor immunity expressed shortly after tumor excision represents active concomitant immunity that is acquired by the host before excision is performed. In contrast, immunity expressed 2 weeks later is based on immunological memory.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3943923     DOI: 10.1002/ijc.2910370216

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  13 in total

1.  Neoadjuvant PD-1 Immune Checkpoint Blockade Reverses Functional Immunodominance among Tumor Antigen-Specific T Cells.

Authors:  Jay Friedman; Ellen C Moore; Paul Zolkind; Yvette Robbins; Paul E Clavijo; Lilian Sun; Sarah Greene; Megan V Morisada; Wojciech K Mydlarz; Nicole Schmitt; James W Hodge; Hans Schreiber; Carter Van Waes; Ravindra Uppaluri; Clint Allen
Journal:  Clin Cancer Res       Date:  2019-10-23       Impact factor: 12.531

2.  Characterization of surgical models of postoperative tumor recurrence for preclinical adjuvant therapy assessment.

Authors:  Jarrod D Predina; Brendan Judy; Veena Kapoor; Aaron Blouin; Louis A Aliperti; Daniel Levine; Olugbenga T Okusanya; Jon Quatromoni; Zvi G Fridlender; Sunil Singhal
Journal:  Am J Transl Res       Date:  2012-04-10       Impact factor: 4.060

Review 3.  Tumor-specific T-cell memory: clearing the regulatory T-cell hurdle.

Authors:  Anik L Côté; Edward J Usherwood; Mary Jo Turk
Journal:  Cancer Res       Date:  2008-03-15       Impact factor: 12.701

4.  Induction of postsurgical tumor immunity and T-cell memory by a poorly immunogenic tumor.

Authors:  Peisheng Zhang; Anik L Côté; Victor C de Vries; Edward J Usherwood; Mary Jo Turk
Journal:  Cancer Res       Date:  2007-07-01       Impact factor: 12.701

5.  Neoadjuvant in situ gene-mediated cytotoxic immunotherapy improves postoperative outcomes in novel syngeneic esophageal carcinoma models.

Authors:  J D Predina; B Judy; L A Aliperti; Z G Fridlender; A Blouin; V Kapoor; B Laguna; H Nakagawa; A K Rustgi; L Aguilar; E Aguilar-Cordova; S M Albelda; S Singhal
Journal:  Cancer Gene Ther       Date:  2011-08-26       Impact factor: 5.987

6.  Frequency of CD4+CD25+Foxp3+ cells in peripheral blood in relation to urinary bladder cancer malignancy indicators before and after surgical removal.

Authors:  Wojciech Jóźwicki; Anna A Brożyna; Jerzy Siekiera; Andrzej T Slominski
Journal:  Oncotarget       Date:  2016-03-08

7.  Mechanisms and immunogenicity of nsPEF-induced cell death in B16F10 melanoma tumors.

Authors:  Alessandra Rossi; Olga N Pakhomova; Andrei G Pakhomov; Samantha Weygandt; Anna A Bulysheva; Len E Murray; Peter A Mollica; Claudia Muratori
Journal:  Sci Rep       Date:  2019-01-23       Impact factor: 4.379

8.  Concomitant tumor immunity to a poorly immunogenic melanoma is prevented by regulatory T cells.

Authors:  Mary Jo Turk; José A Guevara-Patiño; Gabrielle A Rizzuto; Manuel E Engelhorn; Shimon Sakaguchi; Alan N Houghton
Journal:  J Exp Med       Date:  2004-09-20       Impact factor: 14.307

Review 9.  Tumor reductive therapies and antitumor immunity.

Authors:  Huiqin Guo; Kangla Tsung
Journal:  Oncotarget       Date:  2017-06-14

10.  Tumor cure by radiation therapy and checkpoint inhibitors depends on pre-existing immunity.

Authors:  Marka R Crittenden; Lauren Zebertavage; Gwen Kramer; Shelly Bambina; David Friedman; Victoria Troesch; Tiffany Blair; Jason R Baird; Alejandro Alice; Michael J Gough
Journal:  Sci Rep       Date:  2018-05-03       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.